Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotonorm (somatropin) for short stature in children on long-term corticosteroid therapy
2014-004104-30Phase 3
- Sponsor
- Pharmacia
- Start
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of somatropin in growth disorder, juvenile idiopathic arthritis (JIA) and nephrosis, sponsored by Pharmacia. Primary endpoint: Change in height SDS/CA at Year 3.
02
Drugs
somatropin
03
Conditions
growth disorderjuvenile idiopathic arthritis (JIA)nephrosis
Beyond the preview
Go deeper on 2014-004104-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004104-30.